2023-05-25 | Increased Invasive Group A Streptococcal Disease in Ontario | Infectious-diseases |
2023-05-16 | Reminder to report adverse events following immunization | Vaccine-preventable diseases |
2023-05-12 | Multi-drug resistant gonorrhea update
Detection of ceftriaxone non-susceptible Neissseria gonorrhoeae in Ontario (PDF, 712 KB) | Sexual health |
2023-05-11 | 2023–2024 Universal Influenza Immunization Program application process | Vaccine-preventable diseases |
2023-04-20 | Infectious syphilis cases increasing locally (PDF, 292 KB) | Sexual health |
2023-04-17 | Important immunization reminders | Vaccine-preventable diseases |
2023-04-06 | COVID-19 vaccine spring booster recommendations | Vaccine-preventable diseases |
2023-04-04 | Multi-drug resistant gonorrhea identified
Ministry of Health memo on multi-drug resistant gonorrhea (PDF, 100 KB) | Sexual health |
2023-03-29 | New Ontario guidelines for providers offering HIV testing
English (PDF, 541 KB)
Ontario guidelines for providers offering HIV testing
French (PDF, 550 KB)
Lignes directrices ontariennes à l’intention des prestataires de soins qui offrent le dépistage du VIH | Infectious-diseases |
2023-03-20 | Mpox in 2023: Information for clinicians | Vaccine-preventable diseases |
2023-03-17 | XDR Shigella
Memo for further information on XDR Shigella (PDF, 206 KB) | Infectious-diseases |
2023-03-10 | Supply of erythromycin ophthalmic ointment and the importance of adhering to the legislation | Vaccine-preventable diseases |
2023-03-09 | Changes to Lyme disease testing | Infectious-diseases |
2023-02-24 | Respiratory and enteric testing supplies | Infection prevention and control |
2023-02-22 | Measles preparedness | Infectious-diseases |
2023-02-21 | Xylazine/’Tranq’ confirmed locally | Substance use |
2023-01-13 | Public Health Sudbury & Districts’ hours of operation | Public Health Services |
2023-01-11 | Vaccination requirements for school attendance | Vaccine-preventable diseases |
2022-12-20 | COVID-19 vaccine program update | Vaccine-preventable diseases |
2022-11-29 | Influenza vaccine availability | Vaccine-preventable diseases |
2022-11-10 | COVID-19 vaccine update: Guidance on the use of Pfizer BioNTech Comirnaty in immunocompromised children
Flow diagram for COVID-19 fall booster vaccination (PDF, 453 KB) | Vaccine-preventable diseases |
2022-10-18 | COVID-19 vaccine update: Bivalent vaccines (Pfizer and Moderna) now both available in Sudbury and Manitoulin districts | Vaccine-preventable diseases |
2022-10-13 | Updated monkeypox vaccination guidance | Infectious-diseases |
2022-10-05 | Rowan’s Law (concussion safety): Removal-from-sport and return-to-sport protocol requirements | Concussions
|
2022-09-27 | COVID-19 vaccine update: Monovalent Pfizer-BioNTech Comirnaty for children aged 6 months to under 5 years available in Sudbury and Manitoulin districts | Vaccine-preventable diseases |
2022-09-23 | Recognize and report cases of Acute Flaccid Paralysis | Vaccine-preventable diseases |
2022-09-12 | COVID-19 vaccine update: Bivalent Moderna vaccine available in Sudbury and Manitoulin districts | Vaccine-preventable diseases |
2022-09-12 | Influenza vaccine availability for the 2022/2023 season
UIIP package attachments | Vaccine-preventable diseases |
2022-09-02 | Health Care Providers and Public Health Units: Memorandum regarding Aconitine poisoning | Food-safety |
2022-09-01 | COVID-19 vaccine update: Approval of first booster dose for individuals aged 5-11 | Vaccine-preventable diseases |
2022-09-01 | Updated monkeypox vaccination and antiviral guidance | Infectious-diseases |
2022-07-28 | Suspension: Vaccine pick up | Vaccine-preventable diseases |
2022-07-27 | COVID-19 vaccine update: Immunocompromised individuals aged 12 to 17 eligible for second booster dose AND Moderna Spikevax vaccine available for children aged 6 months to 5 years | Vaccine-preventable diseases |
2022-07-26 | Monkeypox PrEP immunization offered to eligible individuals | Infectious-diseases |
2022-07-14 | COVID-19 vaccine update: Expansion of second booster dose eligibility to include all individuals aged 18 and over | Vaccine-preventable diseases |
2022-07-12 | Updated monkeypox treatment guidance and other key resources
Comparison chart MPX vs VZV vs HFMD_June 2022 (PDF, 637 KB) | Infectious-diseases |
2022-06-22 | Treatment for Infectious Syphilis | Sexual health |
2022-06-20 | Monkeypox now reportable to Medical Officer of Health as a newly designated disease of Public Health significance under Provincial legislation
Factsheet: Smallpox and other orthopoxviruses including monkeypox (Ontario Public Health Standards) (PDF, 2.77 MB)
Memorandum: Health Care Providers and Public Health Units RE: Monkeypox (Ministry of Health) (PDF, 52 KB) | Vaccine-preventable diseases |
2022-06-14 | National hypoallergenic infant formula shortage | National Hypoallergenic Infant Formula Shortage |
2022-06-08 | Updated guidance for routine immunization services during COVID-19 | Vaccine-preventable diseases |
2022-05-31 | Interim guidance for post-exposure prophylaxis and treatment of monkeypox
| Infectious-diseases |
2022-05-21 | Reports of confirmed monkeypox in Canada
| Infectious-diseases |
2022-05-11 | Co-circulation of seasonal influenza and SARS-CoV-2 – Considerations for outbreak identification and management | Vaccine-preventable diseases |
2022-05-05 | Increased eligibility for two publicly funded vaccines
| Vaccine-preventable diseases |
2022-05-05 | COVID-19 vaccine update: Certain immunocompromised individuals eligible for second booster and amendments to Ministry of Health’s vaccine administration guide | Vaccine-preventable diseases |
2022-04-26 | CMOH Memo: Severe acute hepatitis of unknown origin in children (PDF, 157 KB) | Severe acute hepatitis |
2022-04-26 | COVID-19 vaccination update: Novovax (Nuvaxovid) | Vaccine-preventable diseases |
2022-04-13 | Clinician responsibilities in Adverse Event Following Immunization (AEFI) monitoring and reporting
| Vaccine-preventable diseases |
2022-04-08 | COVID-19 vaccine strongly recommended for high-risk populations | Vaccine-preventable diseases |
2022-04-07 | COVID-19 vaccine update: Fourth doses for additional populations (second booster) and Moderna primary series for 6 to 11 year olds with moderate to severe immunocompromise | Vaccine-preventable diseases |
2022-03-28 | Sodium in Sudbury and districts drinking water supplies | Levels of sodium in municipal drinking water supplies |
2022-03-03 | Public Health resuming routine immunization services | Vaccine-preventable diseases |
2022-02-18 | COVID-19 vaccine update: Booster doses for all individuals 12 to 17 years of age and updated vaccination timing following COVID-19 infection | Vaccine-preventable diseases |
2022-02-09 | COVID-19 vaccine update: Booster dose eligibility, new groups for a three-dose primary series, and booster dose timing following COVID-19 infection
Ministry of Health COVID-19 vaccine third dose recommendations February 7, 2022 (PDF, 316 KB) | Vaccine-preventable diseases |
2022-02-04 | COVID-19 vaccine update: Guidance for individuals vaccinated outside of Ontario or Canada | Vaccine-preventable diseases |
2022-01-18 | Updates regarding medical exemption and vaccination with COVID-19 vaccines following myocarditis (with or without pericarditis) | Vaccine-preventable diseases |
2022-01-15 | Changes to the management of COVID-19 cases, contacts and outbreaks in highest risk settings | Changes to COVID-19 Case and Contact Management |
2022-01-14 | COVID-19 vaccine update: Fourth doses for select populations | Vaccine-preventable diseases |
2022-01-10 | Public Health services disruption | Public Health Services |
2022-01-05 | Updated COVID-19 testing & case and contact management | Vaccine-preventable diseases |
2022-01-04 | Updates to medical exemptions for COVID-19 vaccine | Vaccine-preventable diseases |
2021-12-24 | Holiday greetings and advisement that rapid changes to COVID-19 case and contact management are underway | Changes to COVID-19 Case and Contact Management |
2021-12-17 | Updates to medical exemptions for COVID-19 vaccine | Vaccine-preventable diseases |
2021-12-17 | COVID-19 vaccine update: Recommendations on expanded booster dose eligibility to protect against Omicron variant | Vaccine-preventable diseases |
2021-12-06 | COVID-19 vaccine update: Recommendations on expanded booster dose and third dose eligibility for individuals aged 50+ | Vaccine-preventable diseases |
2021-11-29 | Call to action: Primary care provider support needed for routine immunization services | Vaccine-preventable diseases |
2021-11-23 | COVID-19 vaccine update: Pfizer-BioNTech Comirnaty COVID-19 vaccine now available for children aged 5 to 11 | Vaccine-preventable diseases |
2021-11-04 | COVID-19 vaccine update: Ministry of Health updates third dose recommendations | Vaccine-preventable diseases |
2021-10-20 | COVID-19 vaccine update: Expanded list of eligible medications for third doses of COVID-19 vaccine | Vaccine-preventable diseases |
2021-10-08 | COVID-19 vaccine update: Verifying immunosuppressive prescriptions for third doses, and expanded eligibility criteria for vulnerable elderly living in congregate settings | Vaccine-preventable diseases |
2021-10-01 | COVID-19 vaccine update: Pfizer-BioNTech Comirnaty® recommended for individuals aged 18 to 24 years | Vaccine-preventable diseases |
2021-10-01 | Influenza vaccine availability for the 2021/2022 season | Vaccine-preventable diseases |
2021-09-24 | Important change to passive tick surveillance in Ontario | Infectious diseases |
2021-09-22 | Update on criteria for medical exemption to COVID-19 vaccination | Vaccine-preventable diseases |
2021-09-17 | Vaccine certificate (passport) requirements and criteria for medical exemption | Vaccine-preventable diseases |
2021-09-16 | COVID-19 vaccine update: Recommendations on expanded third dose eligibility for moderately to severely immunocompromised individuals | Vaccine-preventable diseases |
2021-09-14 | Infection prevention and control key principles for clinical office practice | Infectious diseases |
2021-09-10 | Minimal Contact Intervention (MCI) protocol for COVID-19 vaccine; new vaccine hesitancy survey | Vaccine-preventable diseases |
2021-08-31 | COVID-19 vaccine update: Third dose rollout for select vulnerable populations | Vaccine-preventable diseases |
2021-08-20 | Adverse events following immunization guidance and recommendations | Vaccine-preventable diseases |
2021-08-20 | Treatment for Infectious Syphilis | Sexual health |
2021-08-18 | COVID-19 vaccination update: Policies for high-risk settings; third dose recommendations for vulnerable groups; youth born in 2009 now eligible. | Vaccine-preventable diseases |
2021-08-10 | Pfizer – BioNTech COVID-19 vaccine label to reflect very rare reports of Bell’s Palsy | Vaccine-preventable diseases |
2021-08-06 | Seeking support to improve vaccine uptake among vulnerable groups and priority populations | Vaccine-preventable diseases |
2021-08-05 | Outbreak of hepatitis A infections linked to frozen mangoes | Vaccine-preventable diseases |
2021-07-30 | Reports of Guillain-Barré Syndrome following adenovirus vector COVID-19 vaccines | Vaccine-preventable diseases |
2021-07-21 | Rotavirus vaccine product change | Vaccine-preventable diseases |
2021-07-02 | COVID-19 vaccine updates: Revised vaccine product monographs and accelerated dosing intervals for youth | Vaccine-preventable diseases |
2021-06-29 | Provincial Recommendations and Directive #5
Memorandum: Provincial Recommendations and Directive #5 (Ministry of Health) (PDF, 140 KB) | Vaccine-preventable diseases |
2021-06-24 | Updated recommendations on exceptions to extended dose intervals for COVID-19 vaccines
| Vaccine-preventable diseases |
2021-06-21 | Heterologous COVID-19 mRNA vaccine schedules and resources for health care providers
Q&A for Health Care Providers on mixed COVID-19 mRNA vaccine schedules (Ministry of Health) (PDF, 100 KB) | Vaccine-preventable diseases |
2021-06-18 | Reports of myocarditis and pericarditis after COVID-19 mRNA vaccines | Vaccine-preventable diseases |
2021-06-17 | Missed opportunities for vaccination: It is time to catch up | Vaccine-preventable diseases |
2021-06-13 | Accelerated dosing interval for AstraZeneca clients | Vaccine-preventable diseases |
2021-06-11 | Interchangeability of COVID-19 vaccines, AstraZeneca vaccine Q&A, and quick reference for second doses | Vaccine-preventable diseases |
2021-06-03 | Updated guidance on AstraZeneca second dose options
| Vaccine-preventable diseases |
2021-05-29 | Additional exceptions to the extended dose interval for the COVID-19 vaccine
| Vaccine-preventable diseases |
2021-05-25 | Information for individuals who received a first dose of the AstraZeneca COVID-19 vaccine | Vaccine-preventable diseases |
2021-05-21 | Guidance for employers managing workers with symptoms post COVID-19 vaccination | Vaccine-preventable diseases |
2021-05-15 | High-risk health care workers eligible to receive a second dose of the COVID-19 vaccine at a shortened interval | Vaccine-preventable diseases |
2021-05-14 | Immediate reporting of specific events following AstraZeneca/ COVISHIELD COVID-19 vaccines | Vaccine-preventable diseases |
2021-05-11 | Ontario pauses rollout and administration of AstraZeneca’s COVID-19 vaccine | Vaccine-preventable diseases |
2021-05-11 | COVID-19 vaccine additional exceptions to the extended dosing interval | Vaccine-preventable diseases |
2021-04-23 | Update: Pregnancy now considered highest-risk health condition; now eligible for vaccination | Vaccine-preventable diseases |
2021-04-20 | Administration of COVID-19 vaccine for essential Caregivers of individuals with highest and high-risk health conditions | Vaccine-preventable diseases |
2021-04-16 | Infection prevention and control for COVID-19 | Vaccine-preventable diseases |
2021-04-14 | COVID-19 vaccine dosing intervals, booking and PPE reminders | Vaccine-preventable diseases |
2021-04-14 | Administration of publicly funded COVID-19 vaccine in Ontario and Primary Care Clinics | Vaccine-preventable diseases |
2021-04-08 | Individuals with high-risk health conditions eligible for COVID-19 vaccine – assistance requested to advise patients | Vaccine-preventable diseases |
2021-04-01 | Additional COVID-19 vaccination opportunities for health care workers | Vaccine-preventable diseases |
2021-03-31 | Individuals with highest risk health conditions eligible for COVID-19 vaccine - assistance requested to advise patients | Vaccine-preventable diseases |
2021-03-23 | Guidance for prioritization of Phase 2 populations for COVID-19 vaccination
COVID-19: Guidance for prioritization of Phase 2 populations for COVID-19 vaccination (PDF, 6 MB)
| Vaccine-preventable diseases |
2021-03-22 | 80+ and chronic home care recipients can now book for COVID-19 vaccination | Vaccine-preventable diseases |
2021-03-15 | Centre for Effective Practice (CEP): COVID-19 vaccine resource centre | Vaccine-preventable diseases |
2021-03-05 | 80+ and chronic home care recipients can now pre-register for COVID-19 vaccination
| Vaccine-preventable diseases |
2021-03-01 | Health care workers can now pre-register for COVID-19 vaccination
| Vaccine-preventable diseases |
2021-02-19 | COVID-19 vaccine updates: Allergy information for Clinicians and documentation of verbal attestation for Clinic use (Re-release) | Vaccine-preventable diseases |
2021-02-18 | COVID-19 vaccine updates: Allergy information for Clinicians and documentation of verbal attestation for Clinic use
| Vaccine-preventable diseases |
2021-02-10 | Primary Care Registry (Re-release) | Vaccine-preventable diseases |
2021-02-08 | Primary Care Registry | Vaccine-preventable diseases |
2020-12-16 | Updated COVID-19 guidance for contact identification and management relating to a health care worker | Infectious diseases |
2020-12-14 | COVID-19 vaccines & Provincial rollout
| Vaccine-preventable diseases |
2020-12-04 | Additional Flu vaccine supply: FluMist® Quadrivalent Intra-nasal | Vaccine-preventable diseases |
2020-11-27 | Update: Flu vaccine | Vaccine-preventable diseases |
2020-11-20 | New respiratory outbreak testing prioritization protocol | Infectious diseases |
2020-11-20 | Specimen collection kits for Chlamydia trachomatis and Neisseria gonorrhoeae (NAAT) shortage | Sexual health |
2020-11-09 | Continued shortage of Erythromycin Ophthalmic ointment | Infectious diseases |
2020-10-21 | *New* Infection prevention and control assessment checklist for primary care, specialty, and walk-in clinics during COVID-19
Infection prevention and control assessment for primary care, specialty and walk-in clinics during COVID-19 (PDF, 884 KB)
| Infectious diseases
|
2020-10-02 | Guidance for COVID-19 for children in School and Child Care | Updated COVID-19 guidance for children in school and child care |
2020-09-30 | Universal Influenza Immunization Program implementation package | Infectious diseases |
2020-09-21 | Guidance for COVID-19 following school reopening | Infectious diseases |
2020-09-17 | Updated guidance for immunization services during COVID-19 | Vaccine-preventable diseases |
2020-09-17 | Influenza vaccine updates for the 2020/21 season | Vaccine-preventable diseases |
2020-09-08 | Guidance on the delivery of influenza vaccine during COVID-19 | Vaccine-preventable diseases |
2020-08-17 | Rotavirus vaccine reminder
| Infectious diseases |
2020-07-24 | Chlamydia treatment
Chlamydia treatment (PDF, 200 KB) | Sexual health |
2020-06-30 | COVID-19 Guidance: Primary care providers in a community setting
| Infectious diseases |
2020-04-29 | Guidance for immunization service providers during COVID-19
Guidance for immunization service providers during COVID-19 (PDF, 205 KB) | Infectious diseases |
2020-04-26 | Primary care guidance update (COVID-19)
Ministry of Health, Primary care guidance update (PDF, 91.7 KB) | Infectious diseases |
2020-04-11 | Targeted surveillance for COVID-19 | Infectious diseases |
2020-03-26 | Updated COVID-19 guidance and testing sites
COVID-19 Quick reference Public Health guidance on testing and clearance (PDF, 311 KB) | Updated COVID-19 guidance and testing sites |
2020-03-21 | Communication with Public Health
Primary care COVID-19 guidance 2020-03-20 (PDF, 375 KB) | Communication with Public Health and primary care guidance update |
2020-03-17 | COVID‐19 – healthcare workers returning from travel and criteria for accessing testing | Infectious diseases |
2020-03-16 | Updated COVID-19 recommendations | Infectious diseases |
2020-03-10 | First confirmed case of COVID-19 | Infectious diseases |
2020-01-24 | Update: Novel Coronavirus (2019-nCoV)
Association Chief Medical Officer of Health Letter, January 23, 2020 (PDF, 278 KB)
Case Definition 2019-nCoV, January 23, 2020 (PDF, 278 KB) | Infectious diseases |
2020-01-22 | Resources to Manage Novel Coronavirus Identified in China | Infectious diseases |
2020-01-10 | Vaccination requirements for school attendance
| Vaccine-preventable diseases |
2020-01-03 | Second Case of Hepatitis A Exposure at Real Canadian Superstore, 1485 Lasalle Blvd., Sudbury | Infectious diseases |
2019-12-17 | Hepatitis A Exposure at Real Canadian Superstore, 1485 Lasalle Blvd., Sudbury | Infectious diseases |
2019-12-02 | Administration of Influenza Vaccine
English (PDF, 148 KB)
Administration of Influenza Vaccine CMOH Letter to HCP
French (PDF, 148 KB)
Administration of Influenza Vaccine CMOH Letter to HCP
| Vaccine-preventable diseases |
2019-10-02 | Influenza Surge Planning: Recommendations for Health Care Providers
English (PDF, 102 KB)
Seasonal Influenza Update CMOH Memo FINAL 2019-09-25 shared
French (PDF, 103 KB)
Seasonal Influenza Update CMOH Memo FINAL 2019-09-25 shared
| Vaccine-preventable diseases |
2019-08-13 | Locally-acquired cyclosporiasis in Ontario
| Infectious diseases |
2019-07-29 | Rabies vaccine and immunoglobulin shortages | Vaccine-preventable diseases |
2019-05-22 | Enhanced Surveillance for Pertussis (whooping cough) | Vaccine-preventable diseases |
2019-05-14 | Infectious Syphilis Cases Increasing Locally | Sexual health |
2019-05-14 | Extensively Drug Resistant S. Typhi in Ontario Travellers Returning from Pakistan | Vaccine-preventable diseases |
2019-04-24 | Increasing Influenza A (H3N2) Activity in the Public Health Sudbury & Districts area | Vaccine-preventable diseases |
2019-03-25 | Shortage of erythromycin ophthalmic ointment
Screening Algorithm (PDF, 526 KB)
Response to Lab Results Algorithm (PDF, 522 KB)
| Vaccine-preventable diseases |
2019-03-07 | Provincial Supply of Zostavax® II Vaccine | Vaccine-preventable diseases |
2019-01-24 | Influenza Vaccine Availability in the Public Health Sudbury & Districts Area
| Vaccine-preventable diseases |
2019-01-14 | Ophthalmia Neonatorum and Erythromycin Ophthalmic Ointment Shortage | Vaccine-preventable diseases |
2018-12-27 | Influenza updates including testing availability in the Public Health Sudbury & Districts area | Vaccine-preventable diseases |
2018-11-26 | Discontinuation of the Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis (Td-IPV) Vaccine | Vaccine-preventable diseases |
2018-11-20 | Influenza vaccines for seniors during the 2018/19 influenza season | Vaccine-preventable diseases |
2018-10-23 | Acute flaccid myelitis – Summary and current Ontario situation | Infectious diseases |
2018-10-05 | Listeriosis outbreak
| Infectious diseases |
2018-10-04 | Universal Influenza Immunization Program (UIIP): Influenza Vaccine Product Availability for the 2018/19 Season
| Vaccine-preventable diseases |
2018-07-30 | Vaccine recall in China | Vaccine-preventable diseases |
2018-07-17 | Rotavirus vaccine changes
| Vaccine-preventable diseases |
2018-07-13 | Locally-acquired cyclosporiasis in Ontario
| Infectious diseases |
2018-07-04 | Enhanced Surveillance for Pertussis (whooping cough)
| Vaccine-preventable diseases |
2018-05-30 | Updates to the Health Protection and Promotion Act (HPPA)
Diseases of Public Health Significance (PDF, 364 KB)
| Immunization
Infectious diseases
Vaccine-preventable diseases
|
2018-03-20 | Healthy Growth Initiative
What is BORN? (PDF, 519 KB) | Healthy Growth Initiative |
2018-03-09 | Varicella Activity Among Post-Secondary Students | Vaccine-preventable diseases |
2018-01-29 | Use of quadrivalent influenza vaccine (QIV) during the remainder of the 2017/18 influenza season | Vaccine-preventable diseases |
2017-11-06 | Update on Provincial Vaccine Preventable Disease Outbreaks and Recommended Vaccines
| Vaccine-preventable diseases |
2017-11-03 | First Case of Confirmed Influenza Reported in the Sudbury & District Health Unit Area
| Vaccine-preventable diseases |
2017-10-06 | DTaP-IPV being replaced with DTaP-IPV-Hib
| Vaccine-preventable diseases |
2017-09-17 | Enhanced Surveillance for Mumps | Vaccine-preventable diseases |
2017-09-09 | Cluster of Pediatric Blastomycosis Cases
| Infectious diseases |
2017-08-18
| Lyme disease (letter from the Minister of Health and Long-Term Care)
English (PDF, 99 KB)
Lyme Disease Letter from MOHLTC
French (PDF, 138 KB)
Lyme Disease Letter from MOHLTC | Infectious diseases |
2017-07-14 | Provincial Cyclospora outbreak | Infectious diseases |
2017-04-04 | Measles Activity in Toronto and Peel | Vaccine-preventable diseases |
2017-03-09 | Spectinomycin Shortage | Sexual health |
2016-11-23 | First Case of Confirmed Influenza Reported in the Sudbury & District Health Unit Area | Vaccine-preventable diseases |
2016-11-07 | Antiviral medications for the prevention and treatment of seasonal influenza | Vaccine-preventable diseases |
2016-11-01 | 2016/17 Influenza vaccination recommendations for children | Vaccine-preventable diseases |
2016-10-06 | Reminder re: publicly funded shingles immunization program | Vaccine-preventable diseases |
2016-09-15 | Publicly funded shingles immunization program | Vaccine-preventable diseases |
2016-06-24 | Enhanced surveillance for pertussis (whooping cough) | Vaccine-preventable diseases |
2016-04-23 | Multi-province hepatitis A outbreak linked to frozen berries | Vaccine-preventable disease |
2016-04-18 | Multi-province hepatitis A outbreak linked to frozen berries | Vaccine-preventable disease |
2016-04-16 | Multi-province hepatitis A outbreak linked to frozen berries | Vaccine-preventable diseases |
2016-02-04 | Zika virus infection: laboratory testing information (Public Health Ontario) | Infectious diseases |
2015-11-30 | Influenza confirmed in the Sudbury & District Health Unit area | Vaccine-preventable diseases |
2015-11-12 | Syrian refugee crisis | Memorandum |
2015-11-09 | Administration of Flumist® (Pharmacists) | Immunization |
2015-11-06 | Confirmed case of Tularemia in Sudbury District | Infectious diseases |
2015-10-09 | Universal influenza immunization program materials | Immunization |
2015-09-15 | Surveillance information for Enterovirus D68 | Respiratory |
2015-08-19 | Memo: Meningitis World Scout Jamboree in Japan August 19, 2015 (PDF, 83 KB)
Meningococcal Fact Sheet (PDF, 181 KB)
Meningococcal Fact Sheet (French) (PDF 182 KB) | Vaccine-preventable diseases |
2015-06-24 | PHO Rounds: EV-D68 in Ontario: What happened in 2014 and what’s next? | PHO Rounds: Microbiology |
2015-06-04 | Temporary shortage of DTaP-IPV (Infanrix®-IPV or Quadracel®) | Immunization |
2015-04-30 | Updated 2015 publicly funded immunization schedules for Ontario | Immunization |
2015-03-24 | Immunization requirements for school attendance | Immunization |
2015-02-06 | Measles vaccination schedule details | Vaccine-preventable diseases |
2015-02-04 | Measles activity in Toronto | Vaccine-preventable diseases |
2015-02-01 | Confirmed case of Invasive Group A Streptococcal Infection in Chapleau | Vaccine-preventable diseases |
2015-01-29 | Hepatitis A exposure at Casey's Bar & Grill, 1070 Kingsway Boulevard, Sudbury | Vaccine-preventable diseases |
2015-01-14 | Influenza season: antiviral supply and ordering | Vaccine-preventable diseases |
2015-01-07 | Increased influenza activity in Sudbury & District Health Unit area | Vaccine-preventable diseases |
2014-12-12 | 2014-2015 influenza season | Vaccine-preventable diseases |